Prime Medicine slides after pricing $125.4M stock offering
2025-07-30 23:51:21 ET
More on Prime Medicine
- Prime Medicine: Pressing Forward With Lead Liver Targeting Indications
- Prime Medicine soars as Jones sees it as an acquisition target
- RFK Jr. looks to fast track rare disease drug approvals (updated)
- Seeking Alpha’s Quant Rating on Prime Medicine
- Historical earnings data for Prime Medicine
Read the full article on Seeking Alpha
For further details see:
Prime Medicine slides after pricing $125.4M stock offeringNASDAQ: USA
USA Trading
-0.53% G/L:
$5.655 Last:
598,692 Volume:
$5.70 Open:



